Get started
Author

Katie L. Allen

CT Screening for Lung Cancer: Five-year Prospective Experience
2005 · Stephen J. Swensen, James R. Jett, et al. · Radiology · 636
A prognostic model for advanced stage nonsmall cell lung cancer
2006 · Sumithra J. Mandrekar, Steven E. Schild, et al. · Cancer · 103
The value of combined‐modality therapy in elderly patients with stage III nonsmall cell lung cancer
2007 · Steven E. Schild, Sumithra J. Mandrekar, et al. · Cancer · 53
PDF
The value of combined modality therapy in elderly patients with stage III non-small cell lung cancer (NSCLC)
2007 · S. E. Schild, S. J. Mandrekar, et al. · Journal of Clinical Oncology · 5
Prostate Dimensions and Volume in 700 Patients Undergoing Primary Surgical or Radiotherapeutic Management of Localized Adenocarcinoma: Implications for Design of Minimally Invasive Prostate Cancer Devices
2007 · J.L. Leenstra, B.J. Davis, et al. · International Journal of Radiation Oncology*Biology*Physics · 4
Post-radiotherapy cutaneous mastocytosis
2020 · Katie Allen, Kate Marks, et al. · Diagnostic histopathology · 2
Phase II study of XL184 (cabozantinib) in recurrent or metastatic endometrial cancer: A trial of the PMH, Chicago, and California Phase II Consortia.
2014 · Michelle Wilson, Neesha C. Dhani, et al. · Journal of Clinical Oncology · 1
Evaluation of platinum-based chemotherapy, glutathione metabolic genes, and survival in advanced non small cell lung cancer: A NCCTG 97–24–51 based study
2006 · P. Yang, S. J. Mandrekar, et al. · Journal of Clinical Oncology · 1
Abstract CN02-03: Phase 0 chemoprevention trial of SR13668, a novel AKT inhibitor, in normal volunteers
2010 · Joel M. Reid, Chad Walden, et al. · Cancer Prevention Research
Works count: 9
Citation count: 805
H-index: 4
I10-index: 3
Year
Topic
Type